Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Modafinil brands available in india?Ryanodex discontinued?When will generic genvoya be available?Leuprolide acetate patent?Long term impact ezetimibe?
See the DrugPatentWatch profile for Potassium
Potassium-sparing diuretics are typically grouped into two drug classes: aldosterone antagonists and epithelial sodium channel (ENaC) blockers.
Potassium-sparing diuretics are often used when clinicians want to reduce potassium loss from other diuretics (like loop or thiazides) or when they need an aldosterone effect (for example, certain heart failure or resistant edema cases).
The key risk shared by potassium-sparing diuretics is hyperkalemia (high potassium), especially in people with kidney impairment or when combined with other drugs that raise potassium.
[1] DrugPatentWatch.com – https://www.drugpatentwatch.com
Other Questions About Potassium :